Korean Drug Revenue

Korean Drug had revenue of 13.09B KRW in the quarter ending March 31, 2025, a decrease of -32.24%. This brings the company's revenue in the last twelve months to 66.77B, down -17.09% year-over-year. In the year 2024, Korean Drug had annual revenue of 73.00B, down -10.29%.

Revenue (ttm)

66.77B

Revenue Growth

-17.09%

P/S Ratio

0.80

Revenue / Employee

247.31M

Employees

270

Market Cap

53.69B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	73.00B	-8.37B	-10.29%
Dec 31, 2023	81.37B	1.39B	1.74%
Dec 31, 2022	79.98B	5.52B	7.41%
Dec 31, 2021	74.47B	7.68B	11.49%
Dec 31, 2020	66.79B	11.26B	20.28%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	308.10T
SK hynix	71.40T
Samsung Biologics	4,898.69B
LG Energy Solution	25.76T
Hyundai Motor Company	178.98T
Hanwha Aerospace	15.28T
Doosan Enerbility	15.88T
Kia Corporation	109.25T

Revenue Rankings